Brief: Gyre Therapeutics Reports Second Quarter 2026
07/08/2026 14:04
BRIEF-Gyre Therapeutics Reports Second Quarter 2026 Aug 7 (Reuters) - Gyre Therapeutics, Inc. GYRE.O:
GYRE THERAPEUTICS REPORTS SECOND QUARTER 2026 AND YEAR-TO-DATE FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Source text: ID:nGNX1M3Kfs
Further company coverage: GYRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes